Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | News | Weblinks | Medicines | Poem/Story | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Management of Acute Gout

See also our records on Gout and Gout Prophylaxis.

The objectives in an acute attack are to relieve pain and inflammation as quickly as possible.

General points

An ice pack may be useful, as may rest.1,2 The joint should be elevated and trauma avoided.
The opportunity should also be taken to discuss lifestyle issues such as weight loss, exercise, diet, alcohol consumption, and fluid intake.3
Drug options include:

  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Colchicine
  • Corticosteroids
  • Analgesics

The choice for a particular patient will depend on contraindications, the gap between onset of symptoms and the start of treatment, and risks versus benefits. The European League Against Rheumatism (EULAR) guidelines recommends colchicine and/or NSAIDs as the first-line option for acute gout.4

NSAIDs
  • NSAIDs are the first-line treatment. Starting medication within 24 hours produces rapid relief.5 Consider giving the patient a stock to keep at home.
  • There are no convincing trials supporting the use of a particular NSAID.6 All appear equally effective. Eight drugs are licensed for use in gout. Diclofenac, naproxen and indometacin are generally preferred.3
  • For patients with a high risk of gastro-intestinal adverse events, use a gastro-protective agent, simple analgesia, or colchicine.7
  • Tailor the dose to the needs of the patient bearing in mind age,co-morbidity and interactions with other drugs.8 Aim for the highest tolerable licensed dose but be aware of recent CSM guidance to use NSAIDs for the shortest possible time in view of cardiovascular risk.3
Colchicine
  • Colchicine is an effective treatment for gout, usually starting with a loading dose of 1 mg and increasing by 0.5 mg every 2 hours until toxicity symptoms develop (nausea, vomiting, diarrhoea).4 Titrate up to the maximum licensed dose, according to response.
  • Colchicine is particularly appropriate when NSAIDs are poorly tolerated, in patients with heart failure and in those who are on anticoagulants.9
  • The drug can be effective at lower doses.10 Titrate up to maximum licensed dose, according to response.
Corticosteroids

These can be given orally, intramuscularly, intravenously, or intra-articularly.11

  • These are useful where NSAIDs or colchicine contra-indicated.
  • There are no definitive trials regarding dosage, but UK practice is to use short courses of lower doses - 15 mg/day or less.3,12
  • Intra-articular aspiration and injection may be used in mono-articular gout.4,12
  • Intramuscular cortico-steroid injection can be useful in podagra.3
Analgesics
  • These are useful where all other drug groups contraindicated or as an adjunct for pain-relief.
  • Start with paracetamol, taken regularly rather than 'prn'. If further analgesia is required, add codeine as a separate drug rather than in combination, so individual drugs can be titrated.3,13
What next?

If there is no improvement after 2-3 days:

  • Review the diagnosis (differentials include septic arthritis, non-urate arthropathy, other arthritides and hemochromatosis)
  • Check medicine compliance
  • Increase doses to the maximum

If the patient still fails to improve consider combining treatments, or seek specialist advice.


Document references
  1. Schlesinger N, Schumacher HR Jr; Update on gout. Arthritis Rheum. 2002 Oct 15;47(5):563-5.
  2. Emmerson BT; The management of gout. N Engl J Med. 1996 Feb 15;334(7):445-51. [abstract]
  3. Gout; Clinical Knowledge Summaries (2007).
  4. Zhang W, Doherty M, Bardin T, et al; EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006 Oct;65(10):1312-24. Epub 2006 May 17. [abstract]
  5. Schlesinger N; Management of acute and chronic gouty arthritis: present state. Drugs. 2004;64(21):2399-416. [abstract]
  6. Sutaria S, Katbamna R, Underwood M; Effectiveness of interventions for the treatment of acute and prevention of recurrent gout. Rheumatology (Oxford). 2006 Nov;45(11):1422-31. Epub 2006 Apr 21. [abstract]
  7. Hooper L, Brown TJ, Elliott R, et al; The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ. 2004 Oct 23;329(7472):948. Epub 2004 Oct 8. [abstract]
  8. Bandolier; NSAIDs and adverse effects 2007.
  9. Ahern MJ, Reid C, Gordon TP, et al; Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med. 1987 Jun;17(3):301-4. [abstract]
  10. Morris I, Varughese G, Mattingly P; Colchicine in acute gout. BMJ. 2003 Nov 29;327(7426):1275-6.
  11. Guideline for the management of gout, British Society for Rheumatology (2007).
  12. Underwood M; Diagnosis and management of gout. BMJ. 2006 Jun 3;332(7553):1315-19.
  13. Moore A, Collins S, Carroll D, et al; Paracetamol with and without codeine in acute pain: a quantitative systematic review. Pain. 1997 Apr;70(2-3):193-201. [abstract]

Internet and further reading AcknowledgementsEMIS is grateful to Dr Hayley Willacy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 478
Document Version: 3
DocRef: bgp24973
Last Updated: 3 Jan 2008
Review Date: 2 Jan 2009

Patient Experience










Patient Pharmacy









Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page